Boston Scientific Corporation led a $175 m Series D round in 4C Medical.

Boston Scientific Corporation, a manufacturer of medical devices used in interventional medical specialties, led a $175 m Series D round in 4C Medical, a medical device company. "We are excited to welcome Boston Scientific and thank our shareholders for their support with our financing. The enthusiasm for participation in our ATLAS pivotal trial is palpable, and with this strong capital raise and the backing of Boston Scientific, we look forward to clinically demonstrating the safety and effectiveness of the AltaValve System in treating patients with MR," Saravana Kumar, 4C Medical Chief Executive Officer and President.